Diadema Partners »

Bristol Myers Squibb shares owned by Diadema Partners

Quarter-by-quarter ownership of Bristol Myers Squibb (BMY) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Bristol Myers Squibb

Tip: Access up to 7 years of quarterly data

All positions including Bristol Myers Squibb held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bristol Myers Squibb by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $14M 310k 45.10

More positions owned by Diadema Partners

Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)
Uniqure Nv SHS Put Option (QURE)
Regeneron Pharmaceuticals (REGN)
Viking Therapeutics (VKTX)
Bristol Myers Squibb (BMY)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
BioMarin Pharmaceutical (BMRN)
Avidity Biosciences Ord (RNA)
Agios Pharmaceuticals Call Option (AGIO)
Ultragenyx Pharmaceutical (RARE)
Incyte Corporation Call Option (INCY)
Intellia Therapeutics Call Option (NTLA)
Vaxcyte (PCVX)
Eli Lilly & Co. Put Option (LLY)

View all positions for Diadema Partners

Top funds holding Bristol Myers Squibb

Vanguard Group
BlackRock
State Street Corporation
Jpmorgan Chase & Co
Charles Schwab Investment Management
Geode Capital Management
Ameriprise Financial
Capital Research and Management Company - Division 3
Morgan Stanley
Northern Trust
PRIMECAP Management Company
Ubs Global Asset Management Americas
Independent Franchise Partners
Goldman Sachs Group
Dimensional Fund Advisors

View all funds holding Bristol Myers Squibb